Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vangheluwe

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Biochemical Pharmacology|July 24, 2018
Negative chronotropism, positive inotropism and lusitropism of 3,5-di-t-butyl-4-hydroxyanisole (DTBHA) on rat heart preparations occur through reduction of RyR2 Ca<sup>2+</sup> leakFederica Pessina, Alessandra Gamberucci, Jialin Chen, et al.
Journal of Molecular and Cellular Cardiology|January 24, 2006
Increased phospholamban phosphorylation limits the force-frequency response in the MLP-/- mouse with heart failureGudrun Antoons, Peter Vangheluwe, Paul G A Volders, et al.
Autophagy|July 20, 2017
An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAF<sup>V600E</sup> inhibitor-resistant metastatic melanoma cellsShaun Martin, Aleksandra M Dudek-Peric, Abhishek D Garg, et al.
Biomolecules|February 25, 2023
Novel Green Fluorescent Polyamines to Analyze ATP13A2 and ATP13A3 Activity in the Mammalian Polyamine Transport SystemMarine Houdou, Nathalie Jacobs, Jonathan Coene, et al.
Cardiovascular Research|November 17, 2007
Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffnessAn Van den Bergh, Annelies Vanderper, Peter Vangheluwe, et al.
Neurogenetics|July 18, 2024
Kufor-Rakeb syndrome-associated psychosis: a novel loss-of-function ATP13A2 variant and response to antipsychotic therapyMark Ainsley Colijn, Stephanie Vrijsen, Ping Yee Billie Au, et al.
Cells|August 6, 2020
Necroptosis in Immuno-Oncology and Cancer ImmunotherapyJenny Sprooten, Pieter De Wijngaert, Isaure Vanmeerbeerk, et al.
Biochimica Et Biophysica Acta|January 11, 2011
Thapsigargin affinity purification of intracellular P(2A)-type Ca(2+) ATPasesIlse Vandecaetsbeek, Søren Brøgger Christensen, Huizhen Liu, et al.
Plos One|March 6, 2018
Parkinson disease related ATP13A2 evolved early in animal evolutionDanny Mollerup Sørensen, Tine Holemans, Sarah van Veen, et al.
The Journal of Biological Chemistry|March 8, 2017
Structure/activity relationship of thapsigargin inhibition on the purified Golgi/secretory pathway Ca<sup>2+</sup>/Mn<sup>2+</sup>-transport ATPase (SPCA1a)Jialin Chen, Joren De Raeymaecker, Jannik Brøndsted Hovgaard, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Biochemical Pharmacology|July 24, 2018
Negative chronotropism, positive inotropism and lusitropism of 3,5-di-t-butyl-4-hydroxyanisole (DTBHA) on rat heart preparations occur through reduction of RyR2 Ca<sup>2+</sup> leakFederica Pessina, Alessandra Gamberucci, Jialin Chen, et al.
Journal of Molecular and Cellular Cardiology|January 24, 2006
Increased phospholamban phosphorylation limits the force-frequency response in the MLP-/- mouse with heart failureGudrun Antoons, Peter Vangheluwe, Paul G A Volders, et al.
Autophagy|July 20, 2017
An autophagy-driven pathway of ATP secretion supports the aggressive phenotype of BRAF<sup>V600E</sup> inhibitor-resistant metastatic melanoma cellsShaun Martin, Aleksandra M Dudek-Peric, Abhishek D Garg, et al.
Biomolecules|February 25, 2023
Novel Green Fluorescent Polyamines to Analyze ATP13A2 and ATP13A3 Activity in the Mammalian Polyamine Transport SystemMarine Houdou, Nathalie Jacobs, Jonathan Coene, et al.
Cardiovascular Research|November 17, 2007
Dyslipidaemia in type II diabetic mice does not aggravate contractile impairment but increases ventricular stiffnessAn Van den Bergh, Annelies Vanderper, Peter Vangheluwe, et al.
Neurogenetics|July 18, 2024
Kufor-Rakeb syndrome-associated psychosis: a novel loss-of-function ATP13A2 variant and response to antipsychotic therapyMark Ainsley Colijn, Stephanie Vrijsen, Ping Yee Billie Au, et al.
Cells|August 6, 2020
Necroptosis in Immuno-Oncology and Cancer ImmunotherapyJenny Sprooten, Pieter De Wijngaert, Isaure Vanmeerbeerk, et al.
Biochimica Et Biophysica Acta|January 11, 2011
Thapsigargin affinity purification of intracellular P(2A)-type Ca(2+) ATPasesIlse Vandecaetsbeek, Søren Brøgger Christensen, Huizhen Liu, et al.
Plos One|March 6, 2018
Parkinson disease related ATP13A2 evolved early in animal evolutionDanny Mollerup Sørensen, Tine Holemans, Sarah van Veen, et al.
The Journal of Biological Chemistry|March 8, 2017
Structure/activity relationship of thapsigargin inhibition on the purified Golgi/secretory pathway Ca<sup>2+</sup>/Mn<sup>2+</sup>-transport ATPase (SPCA1a)Jialin Chen, Joren De Raeymaecker, Jannik Brøndsted Hovgaard, et al.
Pageof 9